NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

NOVO.B.DK

281.9

+4.76%↑

GMAB.DK

1,615

+0.28%↑

HLUNB.DK

44.5

+3.92%↑

ZEAL.DK

282.7

+0.35%↑

AMBUB.DK

64.05

-1.23%↓

Kodu・Aktsiate loetelu・Coloplast A-S (Class B)

Search

Coloplast A-S (Class B)

Suletud

384.4 -0.88

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

377.8

Max

387.7

Põhinäitajad
By Trading Economics
Sissetulek	-2.4B -971M
Müük	41M 7.1B
P/E Sektori keskmine	41.674 49.052
Aktsiakasum	-0.16
Dividenditootlus	5.99
Kasumimarginaal	-13.707
Töötajad	17,083
EBITDA	2.8B 5.1B

Soovitused
By TipRanks
Soovitused	Neutraalne
12 kuu keskmine prognoos	+11.86% upside

Dividendid
By Dow Jones
Dividenditootlus Sektori keskmine	5.99% 2.36%

Turustatistika
By TradingEconomics
Turukapital	-2.7B 88B
Eelmine avamishind	385.28
Eelmine sulgemishind	384.4

Coloplast A-S (Class B) Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

10. juuni 2026, 23:36 UTC

Tulu

Correction to Oracle Reports Higher 4Q Profit Article

10. juuni 2026, 23:19 UTC

Kuumad aktsiad

Stocks to Watch: Oracle, Oxford Industries, Humacyte, PureCycle Technologies

10. juuni 2026, 23:09 UTC

Suurimad hinnamuutused turgudel

PureCycle Technologies Slides on Offerings of Stock and Convertible Notes

10. juuni 2026, 23:04 UTC

Tulu

Oracle Reports Higher 4Q Profit on Surging Cloud Revenue -- Update

10. juuni 2026, 20:44 UTC

Suurimad hinnamuutused turgudel

Caterpillar Raises Quarterly Dividend 8%

10. juuni 2026, 23:49 UTC

Omandamised, ülevõtmised, äriostud

Elliott: Northern Star Should Take No Options Off The Table

10. juuni 2026, 23:48 UTC

Omandamised, ülevõtmised, äriostud

Elliott: Reiterates Call For Formal Strategic Review of Northern Star

10. juuni 2026, 23:48 UTC

Omandamised, ülevõtmised, äriostud

Elliott: Northern Star Board Must Be Substantially Strengthened Beyond 1 Additional Director

10. juuni 2026, 23:47 UTC

Market Talk

Nintendo's Stock Recovery Likely Deferred Without Mario Game -- Market Talk

10. juuni 2026, 23:47 UTC

Omandamised, ülevõtmised, äriostud

Elliott: Board Letter Indicates It Doesn't Understand Magnitude of Change Required

10. juuni 2026, 23:46 UTC

Omandamised, ülevõtmised, äriostud

Elliott Investment Management: Northern Star Letter Validates Investment Thesis

10. juuni 2026, 23:38 UTC

Market Talk

Global Equities Roundup: Market Talk

10. juuni 2026, 23:38 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

10. juuni 2026, 23:38 UTC

Market Talk

Nikkei Likely to Fall on Renewed Concerns About Iran Conflict -- Market Talk

10. juuni 2026, 23:32 UTC

Market Talk

Oil Rises Amid Escalating Supply-Disruption Fears -- Market Talk

10. juuni 2026, 23:20 UTC

Market Talk

Wesfarmers's Bunnings Business Looks Resilient to Macro Headwinds -- Market Talk

10. juuni 2026, 22:05 UTC

Market Talk

Correction to Bank of Canada Stays on Hold Market Talk

10. juuni 2026, 21:57 UTC

Tulu

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. juuni 2026, 21:52 UTC

Tulu

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. juuni 2026, 21:35 UTC

Tulu

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. juuni 2026, 21:22 UTC

Tulu

Oracle Stock Slides on Increased Capital Spending -- WSJ

10. juuni 2026, 20:50 UTC

Market Talk

Tulu

Tech, Media & Telecom Roundup: Market Talk

10. juuni 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

10. juuni 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

10. juuni 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

10. juuni 2026, 20:39 UTC

Market Talk

Tulu

Oracle Needs to Raise Less Capital to Fund Data-Center Buildout -- Market Talk

10. juuni 2026, 20:34 UTC

Tulu

Oracle Stock Slides on Mixed Earnings. Software Is an Issue. -- Barrons.com

10. juuni 2026, 20:33 UTC

Tulu

This 'Amazon for Travel' Firm Beat Earnings Expectations. The Stock Is Soaring. -- Barrons.com

10. juuni 2026, 20:33 UTC

Market Talk

Tulu

Global Equities Roundup: Market Talk

10. juuni 2026, 20:33 UTC

Market Talk

Tulu

Oracle Health Expected to Grow Double-Digits This Fiscal Year -- Market Talk

Võrdlus sarnastega

Hinnamuutus

Coloplast A-S (Class B) Prognoos

Hinnasiht

By TipRanks

11.86% tõus

12 kuu keskmine prognoos

Keskmine 901.38 DKK 11.86%

Kõrge 1,056 DKK

Madal 720 DKK

Põhineb 8 Wall Streeti analüütiku instrumendi Coloplast A-S (Class B) 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Neutraalne

8 ratings

2

Osta

4

Hoia

2

Müü

Põhineb 8 analüütiku instrumendi Coloplast A-S (Class B) aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.

Muud aktsiad sektorist

NOVO.B.DK

Novo Nordisk A-S (Class B)

281.9

GMAB.DK

Genmab A-S

1,615

HLUNB.DK

H Lundbeck A-S

44.5

ZEAL.DK

Zealand Pharma A-S

282.7

AMBUB.DK

Ambu A-S

64.05

Live chat